Explore more topics
SEC Form 4 research

GENOMIC HEALTH INC insider transactions

Inspect GENOMIC HEALTH INC's public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001131324
Reporting owners
41
Officers and directors
17
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 0 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Show the table · 34 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Popovits Kimberly J0001333482158
Febbo Phillip G.000164924525
Cohen Fred E000133935817
FUCHS HENRY J0001197355170
MYERS WOODROW A JR000124339920
14159 capital (GP), LLC0001317493591
14159, L.P.00015511381,049
667, L.P.00015511392,118
Baker / Tisch Capital (GP), LLC0001244392182
Baker Biotech Capital (GP), LLC0001244389390
Baker Bros. Advisors (GP) LLC00015805752,197
BAKER BROS. ADVISORS LP00012635082,370
Baker Bros. Capital (GP), LLC0001244390253
Baker Bros. Investments II, L.P.0001551132640
Baker Bros. Investments, L.P.0001551136640
Baker Brothers Life Sciences Capital (GP), LLC0001307729601
Baker Brothers Life Sciences LP00013633642,127
BAKER FELIX00010879404,174
Baker Joffre000133733543
BAKER JULIAN00010879394,416
Baker/Tisch Investments, LP0001551137640
Cole G Bradley0001337798168
COLELLA SAMUEL D000120158081
Goldberg Michael D00013375081
HIBBS KATHY L000126748732
Leber Laura000164919114
LIVINGSTON RANDALL S000123511840
McEachron Kim00016491982
Pla Frederic000164916725
Radford Jason W.00016491998
Schorno Dean L000150968835
Scott Randal W.0001337801165
Shak Steven0001337334155
Vaughn James J000164968980
Popovits Kimberly J ↗Febbo Phillip G. ↗Cohen Fred E ↗FUCHS HENRY J ↗MYERS WOODROW A JR ↗14159 capital (GP), LLC ↗14159, L.P. ↗667, L.P. ↗Baker / Tisch Capital (GP), LLC ↗Baker Biotech Capital (GP), LLC ↗Baker Bros. Advisors (GP) LLC ↗BAKER BROS. ADVISORS LP ↗Baker Bros. Capital (GP), LLC ↗Baker Bros. Investments II, L.P. ↗Baker Bros. Investments, L.P. ↗Baker Brothers Life Sciences Capital (GP), LLC ↗Baker Brothers Life Sciences LP ↗BAKER FELIX ↗Baker Joffre ↗BAKER JULIAN ↗Baker/Tisch Investments, LP ↗Cole G Bradley ↗COLELLA SAMUEL D ↗Goldberg Michael D ↗HIBBS KATHY L ↗Leber Laura ↗LIVINGSTON RANDALL S ↗McEachron Kim ↗Pla Frederic ↗Radford Jason W. ↗Schorno Dean L ↗Scott Randal W. ↗Shak Steven ↗Vaughn James J ↗

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.